Publicacions en què col·labora amb JAVIER RODRIGUEZ CARRIO (59)

2024

  1. Coronary Ectasia and Antinuclear Antibodies: Another Clue to the Role of Immunology in Vascular Disease

    American Journal of Cardiology

  2. Immunology and atherosclerosis: is there an individual ID which defines our susceptibility?

    European heart journal

  3. Targeting Inflammation and Immunology: A Hope for the Frequent Flyers?

    JACC: Cardiovascular Interventions

  4. Type I interferon pathway activation across the antiphospholipid syndrome spectrum: associations with disease subsets and systemic antiphospholipid syndrome presentation

    Frontiers in Immunology, Vol. 15

2023

  1. Comment: Humoral responses against HDL are linked to lipoprotein traits, atherosclerosis and pathogenic pathways during early arthritis stages: Reply

    Rheumatology (Oxford, England), Vol. 62, Núm. 10, pp. e301-e302

  2. Humoral responses against HDL are linked to lipoprotein traits, atherosclerosis, inflammation and pathogenic pathways during early arthritis stages

    Rheumatology (Oxford, England), Vol. 62, Núm. 8, pp. 2898-2907

  3. In-stent restenosis is associated with proliferative skin healing and specific immune and endothelial cell profiles: results from the RACHEL trial

    Frontiers in Immunology, Vol. 14

2021

  1. Malondialdehyde-modified HDL particles elicit a specific IgG response in abdominal aortic aneurysm

    Free Radical Biology and Medicine, Vol. 174, pp. 171-181

  2. Novel Immune Cell Subsets Exhibit Different Associations With Vascular Outcomes in Chronic Kidney Disease Patients—Identifying Potential Biomarkers

    Frontiers in Medicine, Vol. 8

  3. Profiling of Serum Oxylipins During the Earliest Stages of Rheumatoid Arthritis

    Arthritis and Rheumatology, Vol. 73, Núm. 3, pp. 401-413

2020

  1. Erratum: Low-density granulocytes and monocytes as biomarkers of cardiovascular risk in systemic lupus erythematosus (Rheumatology (2020) 59 (1752-1764) DOI: 10.1093/rheumatology/keaa016)

    Rheumatology (United Kingdom)

  2. Glyca levels during the earliest stages of rheumatoid arthritis: Potential use as a biomarker of subclinical cardiovascular disease

    Journal of Clinical Medicine, Vol. 9, Núm. 8, pp. 1-19

  3. IgG anti-high density lipoprotein antibodies are elevated in abdominal aortic aneurysm and associated with lipid profile and clinical features

    Journal of Clinical Medicine, Vol. 9, Núm. 1

  4. IgM anti-phosphorylcholine antibodies associate with senescent and IL-17+ T cells in SLE patients with a pro-inflammatory lipid profile

    Rheumatology (Oxford, England), Vol. 59, Núm. 2, pp. 407-417

  5. Low-density granulocytes and monocytes as biomarkers of cardiovascular risk in systemic lupus erythematosus

    Rheumatology (Oxford, England), Vol. 59, Núm. 7, pp. 1752-1764

  6. The HDL dysfunction gains momentum: is it time for a new approach in rheumatic diseases?

    Rheumatology (Oxford, England), Vol. 59, Núm. 11, pp. 3121-3123

2019

  1. A subset of low density granulocytes is associated with vascular calcification in chronic kidney disease patients

    Scientific Reports, Vol. 9, Núm. 1

  2. Clinical and subclinical cardiovascular disease in female SLE patients: Interplay between body mass index and bone mineral density

    Nutrition, Metabolism and Cardiovascular Diseases, Vol. 29, Núm. 2, pp. 135-143

  3. Exploring the interactions between serum free fatty acids and fecal microbiota in obesity through a machine learning algorithm

    Food Research International, Vol. 121, pp. 533-541

  4. IRF4 and IRGS delineate clinically relevant gene expression signatures in systemic lupus erythematosus and rheumatoid arthritis

    Frontiers in Immunology, Vol. 10, Núm. JAN